Hamzah Bakouni, a postdoctoral trainee, and his colleagues in our laboratory, recently published an article in the Journal of Addiction Medicine in collaboration with Lexie Haquet, M Eugenia Socias, Bernard Le Foll, Ron Lim, Keith Ahamad, and under the supervision of Dr. Didier Jutras-Aswad.   This article focused on describing the titration patterns of two commonly used replacement treatments in prescription-type…

In recognition of Suicide Prevention Week, Gabriel Bastien, PhD candidate in psychiatric sciences at Université de Montréal, gave a presentation on suicide and substance use on February 9, 2023.    Gabriel’s presentation explored the complex relationship between substance use, depression and suicide risk, offering critical perspectives and avenues for intervention.Three key themes were addressed:    Mechanisms involved in the interrelationship of depression…

The Lower-Risk Cannabis Use Guidelines for Psychosis (LRCUG-PSYCH) are evidence-based recommendations for reducing psychosis-related risks when using cannabis. LRCUG-PSYCH were published in the Journal of Dual Diagnosis in 2023 and consist of 11 core public health-oriented recommendations.    For more information, click on the Toolkit tab    Who are the LRCUG-PSYCH for?  The LRCUG-PSYCH are a public mental health resource for psychosis-related education, prevention,…